FindTrial
Sign In

ASSESSMENT OF DURATION OF POSTOPERATIVE PAIN RELIEF IN PATIENTS RECEIVING ULTRASOUND GUIDED NERVE BLOCK WITH BUPIVACAINE (LOCAL ANAESTHETIC) ALONE OR WITH DEXMEDETOMIDINE (SEDATIVE, ANXIOLYTIC) IN PATIENTS UNDERGOING FEMUR (THIGH BONE) FRACTURE SURGERY

ULTRASOUND GUIDED FASCIA ILIACA COMPARTMENT BLOCK USING EITHER BUPIVACAINE OR BUPIVACAINE WITH DEXMEDETOMIDINE FOR POSTOPERATIVE ANALGESIA IN PATIENTS WITH FEMUR FRACTURES

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/03/032154
Enrollment
50
Registered
2021-03-19
Start date
Unknown
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M99-M99- Biomechanical lesions, not elsewhere classified Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: 0.25% BUPIVACAINE, 0.25% BUPIVACAINE WITH DEXMEDETOMIDINE 0.5 mcg/kg: ULTRASOUND GUIDED SINGLE SHOT FASCIA ILIACA COMPARTMENT NERVE BLOCK WILL BE GIVEN PREOPERATIVELY USING EITHER BUPIV

Sponsors

Dr Reshma B M
Lead Sponsor
DR HARSOOR S S
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1. PATIENTS UNDERGOING ELECTIVE FEMUR FRACTURE SURGERIES. 2. PATIENTS BELONGING TO AMERICAN SOCIETY OF ANAESTHESIOLOGISTS PHYSICAL STATUS (ASA-PS) 1 -3

Exclusion criteria

Exclusion criteria: 1. Patients with history of known allergy to local anaesthetic agent and/or dexmedetomidine. 2. Pregnancy and lactation. 3. Infection at the block site. 4. Neurological deficit in lower limbs. 5. Impaired cognition / dementia. 6. Multiple injuries requiring pain medications. 7. Substance / opioid abuse.

Design outcomes

Primary

MeasureTime frame
To assess the duration of postoperative analgesia of USG guided FICB using bupivacaine alone compared with bupivacaine and dexmedetomidine in patients undergoing surgery for fracture femur under spinal anaesthesia.Timepoint: Baseline, 15 minutes after performing block, every 2 hours thereafter for 24 hours—

Secondary

MeasureTime frame
1. TO ASSESS TOTAL ANALGESIC REQUIREMENT POSTOPERTIVELY FOR 12-24 HOURS. 2. PATIENT SATISFACTION SCORE. 3. TO ASSESS SEDATION LEVELS AND SIDE EFFECTS IF ANYTimepoint: ASSESSMENT FOR 24 HOURS POSTOPERATIVELY—

Countries

India

Contacts

Public ContactDr Reshma B M

DR B R AMBEDKAR MEDICAL COLLEGE AND HOSPITAL

lucky3276@gmail.com8892019120

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026